Lais Ragweed M

Ambrosia artemisiifolia, the active ingredient in Lais Ragweed M, is an allergen extract presented as an oromucosal preparation for sublingual use. It is used to treat allergic rhinitis caused by ragweed (Ambrosia artemisiifolia) exposure in patients with documented sensitivity.

GNH USA supplies Lais Ragweed M as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lais Ragweed M is an allergen extract used in allergy immunotherapy for ragweed‑related conditions. - Allergic rhinitis: reduces nasal congestion, sneezing and itching caused by ragweed exposure. - Seasonal allergic rhinitis: improves tolerance to ragweed pollen during peak seasons. - Ragweed‑induced allergic rhinoconjunctivitis: alleviates both nasal and ocular symptoms associated with ragweed allergy.

Lais Ragweed M may cause local and systemic reactions, most of which are mild and transient.

Common Side Effects: - Oral itching or tingling: mild irritation in the mouth. - Throat irritation: sensation of soreness or scratchiness. - Local swelling: mild edema of the lips or tongue. - Nausea: occasional upset stomach. - Headache: mild to moderate intensity. - Mild cough: brief irritation of the airway.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Severe swelling of the throat or tongue: may compromise breathing. - Respiratory distress: difficulty breathing or wheezing. - Systemic allergic reaction: widespread hives or rash. - Angioedema: rapid swelling of face, lips, or eyes. - Cardiovascular collapse: rare drop in blood pressure.

Before initiating therapy with Lais Ragweed M, consider the following precautions. - Medical evaluation: confirm ragweed allergy through appropriate testing. - Existing severe asthma: assess risk as immunotherapy may exacerbate symptoms. - Recent anaphylaxis: avoid use until fully recovered and cleared by a physician. - Concomitant beta‑blocker therapy: monitor closely due to potential interference with emergency treatment of reactions. - Pregnancy and breastfeeding: use only if clearly needed and prescribed by a healthcare professional. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct light.

Lais Ragweed M may interact with other medications or therapies.

Major Interactions (Avoid): - Concurrent allergen immunotherapy products: may increase risk of systemic reactions. - Beta‑blockers: can mask symptoms of anaphylaxis and interfere with emergency treatment.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance risk of angioedema. - NSAIDs: can potentiate allergic responses in sensitive individuals. - Immunosuppressants: may reduce efficacy of immunotherapy. - Antihistamines: may blunt clinical assessment of reactions. - Live vaccines: schedule administration apart from immunotherapy sessions.